Global Bio-chem Technology Group Company Limited risk profile
44 Elevated one input has moved against it
Measured 1 September 2026 from GLY's filed statements. Recomputed nightly.
44 (Elevated), driven by Cash conversion at 87, over 5 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 35 | Normal | Stable | Average daily turnover — $21 |
| Operating pressure | 24 | Normal | Worsening | Costs outgrowing revenue — -1.5 percentage points |
| Cash conversion | 87 | Acute | Worsening | Capital spending against operating cash — -2.86x |
| Leverage and coverage | 64 | Stretched | Worsening | Interest cover — 1.88x |
| Competitive position | 39 | Normal | Stable | Operating-margin gap against peers — -8.8 percentage points |
| Concentration | Reads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company. | |||
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.
Consumer Defensive companies with a risk reading
Walmart Inc 43Costco Wholesale Corp 40Coca-Cola Company 30Procter & Gamble Company 34Philip Morris International Inc 24Nestle S.A. 45Nestlé S.A 45L'Oréal S.A. 32PepsiCo Inc 43Anheuser-Busch InBev SA/NV 35Unilever plc 42Unilever PLC 42
Financials, valuation and price history for Global Bio-chem Technology Group Company Limited